A., Safstrom, K. and Walfridsson, H. (2008) Source of inflammatory markers in patients with atrial fibrillation. Europace, 10, 848-853. http://europace.oxfordjournals.org/content/10/7/848.full doi:10.1093/europace/eun111
  • Ellinor, P.T., Low, A., Patton, K.K., Shea, M.A. and MacRae, C.A. (2006) C-reactive protein in lone atrial fibrillation. American Journal of Cardiology, 97, 1346-1350. http://www.sciencedirect.com/science/article/pii/S0002914906001585 doi:10.1016/j.amjcard.2005.11.052
  • Roldan, V., Marin, F., Blann, A.D., Garcia, A., Marco, P., Sogorb, F. and Lip, G.Y. (2003) Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. European Heart Journal, 24, 1373-1380. http://eurheartj.oxfordjournals.org/content/24/14/1373.full doi:10.1016/S0195-668X(03)00239-2
  • Scridon, A., Morel, E., Nonin-Babary, E., Girerd, N., Fernandez, C., and Chevalier, P. (2012) Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. Europace, in press. http://europace.oxfordjournals.org/content/early/2012/02/02/europace.eur418.full
  • Li, J., Hampton, T., Morgan, J.P. and Simons, M. (1997) Stretch-induced VEGF expression in the heart. Journal of Clinical Investigations, 100, 18-24. http://www.jci.org/articles/view/119510
  • Wong, A.K., Marais, H.J., Jutzy, K., Capestany, G.A. and Marais, G.E. (1991) Isolated atrial infarction in a patient with single vessel disease of the sinus node artery. Chest, 100, 255-256. http://chestjournal.chestpubs.org/content/100/1/255.full.pdf+html doi:10.1378/chest.100.1.255
  • Thijssen, V.L., van der Velden, H.M., van Ankeren, E.P., Ausma, J., Allessie, M.A., Borgers, M., van Eys, G.J. and Jongsma, H.J. (2002) Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovascular Research, 54, 427-437. http://cardiovascres.oxfordjournals.org/content/54/2/427.full doi:10.1016/S0008-6363(02)00260-2
  • Freeman, M.R., Scheck, F.X., Gagnon, M.L., Corless, C., Soker, S., Niknejad, K., Peoples, G.E. and Klagsbrun, M. (1995) Peripheral blood T-lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Research, 55, 4140-4145. http://cancerres.aacrjournals.org/content/55/18/4140.full.pdf
  • Gaudry, M., Bregerie, O., Andrieu, V., El Benna, J., Pocidalo, M.A. and Hakim, J. (1997) Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood, 90, 4153-4161. http://bloodjournal.hematologylibrary.org/content/90/10/4153.full.pdf
  • Mohle, R., Green, D., Moore, M.A.S., Nachman, R.L. and Rafii, S. (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proceedings of the National Academy of Sciences USA, 94, 663-668. http://www.ncbi.nlm.nih.gov/pubmed/9012841 doi:10.1073/pnas.94.2.663
  • Seko, Y., Seko, Y., Takahashi, N., Shibuya, M. and Yazaki, Y. (1999) Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochemical and Biophysical Research Communications, 254, 462-465. http://www.sciencedirect.com/science/article/pii/S0006291X98999697 doi:10.1006/bbrc.1998.9969
  • Kallergis, E.M., Manios, E.G., Kanoupakis, E.M., Mavrakis, H.E., Arfanakis, D.A., Maliaraki, N.E., Lathourakis, C.E., Chlouverakis, G.I. and Vardas, P.E. (2008) Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. Journal of the American College of Cardiology, 52, 211-215. http://content.onlinejacc.org/cgi/content/full/52/3/211
  • Gramley, F., Lorenzena, J., Koellensperger, E., Kettering, K., Weiss, C. and Munzel, T. (2010) Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway. International Journal of Cardiology, 143, 405-413. http://www.sciencedirect.com/science/article/pii/S0167527309003969 doi:10.1016/j.ijcard.2009.03.110
  • Chaudhary, N.I., Roth, G.J., Hilberg, F., Müller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A. and Park, J.E. (2007) Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. European Respiratory Journal, 29, 976-985. http://erj.ersjournals.com/content/29/5/976.full doi:10.1183/09031936.00152106
  • Hamada, N., Kuwano, K., Yamada, M., Hagimoto, N., Hiasa, K., Egashira, K., Nakashima, N., Maeyama, T., Yoshimi, M. and Nakanishi, Y. (2005) Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. Journal of Immunology, 175, 1224-1231. http://www.jimmunol.org/content/175/2/1224.full
  • Motomura, Y., Kanbayashi, H., Khan, W.I., Deng, Y., Blennerhassett, P.A., Margetts, P.J., Gauldie, J., Egashira, K. and Collins, S.M. (2005) The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer. American Journal of Physiology: Gastrointestinal and Liver Physiology, 288, G143-G150. http://ajpgi.physiology.org/content/288/1/G143.full
  • Jahangir, A., Munger, T.M., Packer, D.L. and Crijns, H.J.G.M. (2001) Atrial fibrillation. In: Podrid, P.J. and Kowey, P.R. Eds., Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management, 2nd Edition, Lippincott Williams & Wilkins, Philadelphia, 457-499.
  • Tsang, T.S., Gersh, B.J., Appleton, C.P., Tajik, A.J., Barnes, M.E., Bailey, K.R., Oh, J.K., Leibson, C., Montgomery, S.C. and Seward, J.B. (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology, 40, 1636-1644. http://content.onlinejacc.org/cgi/content/full/40/9/1636 doi:10.1016/S0735-1097(02)02373-2
  • Wang, T.J., Parise, H., Levy, D., D’Agostino, R.B. Sr., Wolf, P.A., Vasan, R.S. and Benjamin, E.J. (2004) Obesity and the risk of new-onset atrial fibrillation. Journal of the American Medical Association, 292, 2471-2477. http://jama.ama-assn.org/content/292/20/2471.full doi:10.1001/jama.292.20.2471
  • Gami, A.S., Pressman, G., Caples, S.M., Kanagala, R., Gard, J.J., Davison, D.E., Malouf, J.F., Ammash, N.M., Friedman, P.A. and Somers, V.K. (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation, 110, 364-367. http://circ.ahajournals.org/content/110/4/364.full doi:10.1161/01.CIR.0000136587.68725.8E
  • Verdecchia, P., Reboldi, G., Gattobigio, R., Bentivoglio, M., Borgioni, C., Angeli, F., Carluccio, E., Sardone, M.G. and Porcellati, C. (2003) Atrial fibrillation in hypertension: Predictors and outcome. Hypertension, 41, 218-223. http://hyper.ahajournals.org/content/41/2/218.full
  • Aviles, R.J., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., Tracy, R.P., Van Wagoner, D.R., Psaty, B.M., Lauer, M.S. and Chung, M.K. (2003) Inflammation as a risk factor for atrial fibrillation. Circulation, 108, 3006-3010. http://circ.ahajournals.org/content/108/24/3006.full doi:10.1161/01.CIR.0000103131.70301.4F
  • Nieuwlaat, R., Prins, M.H., Le Heuzey, J.Y., Vardas, P.E., Aliot, E., Santini, M., Cobbe, S.M., Widdershoven, J.W.M.G., Baur, L.H., Levy, S. and Crijns, H.J.G.M. (2008) Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on Atrial Fibrillation. European Heart Journal, 29, 1181-1189. http://eurheartj.oxfordjournals.org/content/29/9/1181.full doi:10.1093/eurheartj/ehn139
  • Journal Menu >>